5.2 Moisture-Associated Skin Damage & Chemical Irritant Dermatitis
Key Takeaways
- Peristomal Moisture-Associated Skin Damage (PMASD) and Chemical Irritant Contact Dermatitis (ICD) occur when caustic stomal effluent penetrates the skin barrier, exposing the epidermis to active pancreatic proteases (trypsin, chymotrypsin), lipases, bile acids, or alkaline urine ($pH > 7.0$) colonized with urea-splitting bacteria.
- The diagnostic hallmark of chemical ICD is a sharply demarcated, bright red, glistening, denuded area of partial-thickness epidermal loss that precisely mirrors the pattern of effluent leakage or the gap between the stoma base and the barrier opening.
- The evidence-based WOCN 'crusting' technique employs hydrocolloid stoma powder dusted exclusively onto moist, denuded skin, followed by thorough dusting away of loose excess powder and sealing with a non-alcohol liquid barrier film or spray to create a dry, secure bonding surface.
- Skin barrier apertures must be sized to within 1/16 to 1/8 inch (1.5 to 3.0 mm) of the stoma base to prevent peristomal effluent exposure while avoiding mechanical constriction and stomal mucosal laceration.
- For flush, retracted, or tilted stomas causing undermining effluent, the clinical solution requires convexity (soft or deep) combined with an ostomy support belt and moldable hydrocolloid barrier rings or paste to achieve a dynamic mechanical seal.
Moisture-Associated Skin Damage & Chemical Irritant Dermatitis
Quick Summary: Chemical Irritant Contact Dermatitis (ICD), the most prevalent form of Peristomal Moisture-Associated Skin Damage (PMASD), results from direct, sustained contact between caustic stomal effluent and the peristomal epidermis. Ileostomy effluent delivers high concentrations of active proteolytic and lipolytic enzymes that rapidly digest stratum corneum proteins, while urostomy effluent—especially when alkaline ($pH > 7.0$) due to urea-splitting bacteria—induces chemical burns and encrustations. Treatment centers on restoring the skin barrier via the WOCN-standard "crusting" technique (hydrocolloid powder sealed with non-alcohol barrier spray), resizing the barrier opening to within $1/16\text{ to }1/8\text{ inch}$ ($1.5\text{–}3.0\text{ mm}$), and correcting leakage dynamics with convexity and barrier rings.
Effluent containment is the primary objective of any ostomy management plan. When containment fails, even minor exposure to effluent initiates rapid epidermal degradation, creating intense burning pain and preventing subsequent pouch adherence.
Pathophysiology: Effluent Composition & Enzymatic Virulence
The biochemical composition of stomal effluent determines the speed and severity of chemical skin breakdown across different ostomy diversions:
EFFLUENT CAUSTIC POTENTIAL SPECTRUM
┌────────────────────────────────────────────────────────────────────────┐
│ ILEOSTOMY EFFLUENT (Highest Enzymatic Virulence) │
│ • Active Proteases: Trypsin, Chymotrypsin, Elastase │
│ • Pancreatic Lipases: Degrades Intercellular Lipids │
│ • Caustic Bile Salts: Acts as powerful biological detergent │
│ • Rapid onset: Epidermal denudation occurs within 30–60 minutes │
├────────────────────────────────────────────────────────────────────────┤
│ UROSTOMY EFFLUENT (High Moisture + Alkaline Encrustation Risk) │
│ • Continuous aqueous exposure -> Severe cellular overhydration/maceration│
│ • Urea-splitting bacteria (*Proteus*): Converts Urea -> Ammonia ($NH_3$)│
│ • Alkaline pH ($> 7.0$): Precipitates calcium phosphate crystals / PEH │
├────────────────────────────────────────────────────────────────────────┤
│ ASCENDING / TRANSVERSE COLOSTOMY (Moderate Enzymatic Risk) │
│ • Semiliquid/pasty stool with residual digestive enzymes & mucinases │
├────────────────────────────────────────────────────────────────────────┤
│ DESCENDING / SIGMOID COLOSTOMY (Low Enzymatic Risk) │
│ • Formed stool; minimal active enzymes; damage driven by bacterial load│
└────────────────────────────────────────────────────────────────────────┘
1. Ileostomy Effluent: Proteolytic & Lipolytic Digestion
Liquid effluent from the terminal ileum is rich in unneutralized pancreaticobiliary secretions:
- Proteolytic Enzymes (Trypsin, Chymotrypsin, Carboxypeptidases): Rapidly cleave peptide bonds in corneodesmosomes and intracellular keratin, causing cellular detachment (acantholysis) and stripping the stratum corneum.
- Pancreatic Lipases & Bile Salts: Act as biological detergents, solubilizing the intercellular lipid bilayers (ceramides, cholesterol, fatty acids) and eliminating the skin's moisture barrier within 30 to 60 minutes of contact.
2. Urostomy Effluent: Maceration, Alkalinity & Pseudoepitheliomatous Hyperplasia
Urinary diversion effluent presents unique chemical challenges:
- Chronic Maceration: Continuous fluid exposure swells corneocytes, disrupts the lamellar lipid organization, and increases cutaneous permeability by up to 10-fold.
- Alkaline Urine & Bacterial Action: When colonized by urea-splitting microorganisms (Proteus mirabilis, Klebsiella pneumoniae, Pseudomonas aeruginosa), bacterial urease hydrolyzes urea into free ammonia ($NH_3$):
- Consequences of Alkalinity: High pH causes chemical burning and precipitates insoluble calcium phosphate and magnesium ammonium phosphate (struvite) crystals onto the skin and stoma, manifesting as gritty white encrustations and triggering Pseudoepitheliomatous Hyperplasia (PEH) (thickened, hyperkeratotic, verrucous "wart-like" cobblestone lesions).
Clinical Presentation & Differential Diagnosis
Recognizing the precise morphological pattern of Chemical ICD is critical to distinguish it from fungal infections and allergic reactions.
| Diagnostic Parameter | Chemical Irritant Contact Dermatitis (ICD) | Peristomal Candidiasis | Allergic Contact Dermatitis (ACD) |
|---|---|---|---|
| Morphological Pattern | Mirror-image or circumferential halo matching the exact area of effluent leakage or opening gap. | Bright red confluent erythema with distinct satellite papules and pustules spreading past margins. | Erythema, edema, and microvesicles matching the exact geometric footprint of wafer or tape. |
| Skin Texture / Base | Moist, glistening, weeping, partial-thickness epidermal denudation; macerated white margins. | Diffuse inflammatory redness with superficial white scaling and peripheral pinpoint pustules. | Intensely edematous, erythematous, vesicular, oozing, or lichenified plaque. |
| Patient Symptoms | Intense burning, stinging, raw pain, especially when effluent contacts skin or during pouch change. | Intense pruritus (itching) and burning sensation exacerbated by heat and moisture. | Severe, relentless pruritus (itching); mild burning or soreness. |
| Underlying Root Cause | Inadequately sized wafer opening, barrier undermining, or flush/retracted stoma leak. | Fungal proliferation under warm, moist, occlusive barrier; recent antibiotic therapy. | Type IV delayed hypersensitivity to adhesive tackifiers, acrylates, or additives. |
Evidence-Based Clinical Interventions: The WOCN "Crusting" Technique
When peristomal skin is denuded, wet, and weeping serous fluid, standard hydrocolloid skin barriers cannot adhere. The WOCN Crusting Technique (Modified Powder-and-Barrier-Film Seal) creates a dry, prosthetic barrier that shields raw nerve endings and provides a receptive adhesive base.
THE EVIDENCE-BASED CRUSTING PROTOCOL
┌────────────────────────────────────────────────────────────────────────┐
│ STEP 1: Gentle Cleansing & Drying │
│ • Cleanse skin with warm tap water; pat thoroughly dry. │
│ • Avoid soaps containing oils, lotions, or moisturizers. │
├────────────────────────────────────────────────────────────────────────┤
│ STEP 2: Targeted Hydrocolloid Powder Application │
│ • Dust hydrophilic stoma powder (pectin/gelatin/carboxymethylcellulose)│
│ ONLY on moist, denuded, weeping areas. │
├────────────────────────────────────────────────────────────────────────┤
│ STEP 3: Thorough Dusting Away of Excess Powder │
│ • Gently wipe or brush away ALL loose, excess powder. │
│ • [CRITICAL]: Powder should remain ONLY where bound to wet exudate. │
├────────────────────────────────────────────────────────────────────────┤
│ STEP 4: Sealing with Non-Alcohol Barrier Spray / Wipe │
│ • Dab or spray a non-alcohol liquid barrier film over the powdered area│
│ • Allow 5 to 10 seconds to dry into a smooth, glossy, protective seal. │
│ • Optional: Repeat Steps 2–4 once for deep denudation (2-layer max). │
└────────────────────────────────────────────────────────────────────────┘
Important: The #1 Error in Crusting: Leaving loose, unbound stoma powder on intact dry skin creates a dry chalky layer that prevents the adhesive wafer from bonding, causing catastrophic appliance leakage within hours. Powder must be dusted off vigorously until only the exudate-bound powder remains.
Warning: Never use alcohol-containing skin prep wipes on denuded peristomal skin. Alcohol causes severe, excruciating stinging and chemical pain. Always specify non-alcohol (silicone- or cyanoacrylate-based) liquid barrier films.
Skin Barrier Aperture Resizing & Mechanics
The most frequent cause of peristomal chemical ICD is an incorrectly sized barrier opening.
Aperture Sizing Guidelines
- Target Measurement: The skin barrier aperture must be cut or molded to within 1/16 to 1/8 inch (1.5 to 3.0 mm) of the stoma base circumference.
- Postoperative Stomal Edema Shrinkage: Postoperative stomas experience substantial edema that resolves over 6 to 8 weeks post-surgery. During this period, the stoma diameter can decrease by 30% to 50%.
- Re-measurement Protocol: Measure the stoma base with a circular measuring guide at every pouch change during the first 6 to 8 weeks. Failing to downsize the opening as edema subsides exposes an expanding ring of peristomal skin to corrosive effluent.
[INCORRECT: Aperture Too Large] [CORRECT: 1/16" to 1/8" Clearance]
┌─────────────────────────────┐ ┌─────────────────────────────┐
│ Wafer Opening │ │ Wafer Opening │
│ ┌─────────────────────┐ │ │ ┌─────────────────────┐ │
│ │ [Exposed Skin] │ │ │ │ [1/16" Clear Gap] │ │
│ │ ┌─────────────┐ │ │ │ │ ┌─────────────┐ │ │
│ │ │ STOMA │ │ │ │ │ │ STOMA │ │ │
│ │ │ │ │ │ │ │ │ │ │ │
│ │ └─────────────┘ │ │ │ │ └─────────────┘ │ │
│ │ Chemical ICD Zone │ │ │ │ Protected by Ring │ │
│ └─────────────────────┘ │ │ └─────────────────────┘ │
└─────────────────────────────┘ └─────────────────────────────┘
Barrier Rings, Pastes, Convexity & Belt Mechanics
When abdominal topography, flush stomas, or skin folds permit effluent to undermine the wafer, mechanical accessory solutions are mandatory.
Moldable Hydrocolloid Rings vs. Pectin-Based Paste
- Moldable Hydrocolloid Barrier Rings / Seals: Alcohol-free, non-stinging rings that can be stretched, shaped, or layered. When exposed to moisture, they swell to create a dynamic "turtleneck" collar around the stoma base, filling peri-stomal troughs and protecting the junction.
- Pectin-Based Ostomy Paste: Functionally serves as caulking to level deep scars, creases, or dips—it is not a glue. Traditional pastes contain 15% to 20% alcohol (which stings severely on broken skin). If paste is used, apply it directly to the wafer or into scars, and allow it to "flash off" for 1 to 2 minutes before application.
Convexity Mechanics & Support Belts
When a stoma is flush ($< 10\text{ mm}$ protrusion), retracted, tilted, or situated in a deep abdominal crease, a flat barrier allows effluent to pool and undermine the adhesive seal.
+---------------------------------------------------------------------------------------------------+
| CONVEXITY SELECTION & APPLICATION MATRIX |
+---------------------------------------------------------------------------------------------------+
| Clinical Feature | Flat Skin Barrier | Soft Convexity | Deep / Rigid Convexity |
+------------------------+---------------------------+---------------------------+---------------------------+
| Stoma Protrusion | Ideal bud (15–25 mm) | Flush (0–5 mm) or soft | Retracted below skin level|
| | with central lumen | peristomal plane | or deep rigid creasing |
+------------------------+---------------------------+---------------------------+---------------------------+
| Peristomal Abdomen | Firm, flat, uniform | Soft, flaccid abdomen, | Firm abdomen with deep |
| | abdominal wall plane | tender incision nearby | recessed stomal trough |
+------------------------+---------------------------+---------------------------+---------------------------+
| Biomechanical Action | Relies solely on surface | Applies gentle uniform | Delivers high focal |
| | adhesive contact | pressure to pop stoma out | pressure to evert stoma |
+------------------------+---------------------------+---------------------------+---------------------------+
| Ostomy Belt Role | Optional | Recommended for stability | **Mandatory** to maintain |
| | | | continuous convex plateau |
+------------------------+---------------------------+---------------------------+---------------------------+
Exam Tip: Ostomy Support Belt Alignment: An ostomy belt must connect to the belt tabs at the 3:00 and 9:00 positions and pull in a direct, horizontal line with the stoma. The tension should allow two fingers to slide comfortably beneath the belt. Overtightening creates pressure necrosis, tension blisters, and peristomal ulcerations.
An ostomy nurse is instructing a patient on performing the evidence-based WOCN crusting technique for moist, denuded peristomal skin. Which step is essential to ensure that the skin barrier wafer adheres securely to the abdomen?
A patient with an ileostomy presents with a sharply demarcated, bright red, weeping crescent of peristomal denudation located strictly between the 4:00 and 8:00 positions adjacent to the stoma base. The remaining peristomal skin under the wafer is intact. Which etiology and clinical intervention are indicated?
A patient with an ileal conduit urostomy presents with thick, white, gritty encrustations and cobblestone-like verrucous papules (pseudoepitheliomatous hyperplasia) surrounding the stoma. Peristomal urine dipstick reveals a pH of 8.0. What is the underlying pathophysiology and appropriate management plan?
A patient with a flush ileostomy (stoma protruding 2 mm above skin level) located in a soft, flaccid lower abdomen experiences recurrent effluent undermining and chemical skin breakdown every 24 to 36 hours despite using a flat skin barrier and paste. What modification to the pouching system should the nurse recommend?